Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 16Lymphoma, Non-Hodgkin 10Myeloproliferative Disorders 9Lymphoma, Follicular 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Primary Myelofibrosis 7Lymphoma, Mantle-Cell 7Leukemia, Biphenotypic, Acute 7Leukemia 7Anemia, Refractory, with Excess of Blasts 7Lymphoma, T-Cell 6Lymphoma 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Anemia, Aplastic 5Waldenstrom Macroglobulinemia 4Polycythemia Vera 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Hematologic Neoplasms 4Congenital Abnormalities 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3

Interventions

Lenalidomide 7Dexamethasone 5daratumumab 4Calcium Dobesilate 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Curcumin 3isatuximab 2iberdomide 2Leflunomide 2pomalidomide 1poly ICLC 1piperine 1pembrolizumab 1ixazomib 1fludarabine phosphate 1fludarabine 1citarinostat 1Watchful Waiting 1Urination 1Stem Cell Transplantation 1Resistance Training 1Propranolol 1Probiotics 1Peripheral Blood Stem Cell Transplantation 1PVX-410 vaccine 1Observation 1Metformin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoldering Multiple Myeloma × Peripheral Blood Stem Cell Transplantation × 1 year × Clear all
NCT00114101 2026-05-29

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

National Cancer Institute (NCI)

Phase 3 Active not recruiting
460 enrolled 11 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡